Home/Filings/4/0001181431-11-018983
4//SEC Filing

METCALF BRIAN W 4

Accession 0001181431-11-018983

CIK 0000879169other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 4:13 PM ET

Size

30.8 KB

Accession

0001181431-11-018983

Insider Transaction Report

Form 4
Period: 2011-03-16
METCALF BRIAN W
Chief Drug Discovery Scientist
Transactions
  • Exercise/Conversion

    Common Stock

    2011-03-16$11.06/sh+2,777$30,714116,504 total
  • Exercise/Conversion

    Non-Qualified Stock Options

    2011-03-1850,0000 total
    Exercise: $11.06Exp: 2012-02-26Common Stock (50,000 underlying)
  • Sale

    Common Stock

    2011-03-18$14.31/sh200$2,86266,504 total
  • Exercise/Conversion

    Non-Qualified Stock Options

    2011-03-162,7770 total
    Exercise: $11.06Exp: 2012-02-26Common Stock (2,777 underlying)
  • Sale

    Common Stock

    2011-03-18$14.25/sh50,000$712,50066,504 total
  • Exercise/Conversion

    Common Stock

    2011-03-18$5.97/sh+2,777$16,579176,504 total
  • Exercise/Conversion

    Non-Qualified Stock Options

    2011-03-1873,4330 total
    Exercise: $11.06Exp: 2012-02-26Common Stock (73,433 underlying)
  • Exercise/Conversion

    Incentive Stock Options

    2011-03-182,7770 total
    Exercise: $5.97Exp: 2012-11-06Common Stock (2,777 underlying)
  • Exercise/Conversion

    Common Stock

    2011-03-18$11.06/sh+50,000$553,000116,504 total
  • Exercise/Conversion

    Common Stock

    2011-03-18$11.06/sh+73,433$812,169139,937 total
  • Exercise/Conversion

    Common Stock

    2011-03-18$11.06/sh+33,790$373,717173,727 total
  • Exercise/Conversion

    Non-Qualified Stock Options

    2011-03-1647,2230 total
    Exercise: $5.97Exp: 2012-11-06Common Stock (47,223 underlying)
  • Exercise/Conversion

    Incentive Stock Options

    2011-03-1833,7900 total
    Exercise: $11.06Exp: 2012-02-26Common Stock (33,790 underlying)
  • Exercise/Conversion

    Common Stock

    2011-03-16$5.97/sh+47,223$281,921113,727 total
  • Sale

    Common Stock

    2011-03-16$14.25/sh50,000$712,50066,504 total
  • Sale

    Common Stock

    2011-03-18$14.30/sh58,300$833,690118,204 total
  • Sale

    Common Stock

    2011-03-18$14.25/sh51,500$733,87566,704 total
Footnotes (2)
  • [F1]Beginning November 7, 2002, options become exercisable in 37 installments, with the first installment of 25% vesting after one year and the remainder vesting monthly over three years.
  • [F2]Beginning February 27, 2002, options become exercisable in 37 installments, with the first installment of 25% vesting after one year and the remainder vesting monthly over three years.

Documents

1 file

Issuer

INCYTE CORP

CIK 0000879169

Entity typeother

Related Parties

1
  • filerCIK 0001234564

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:13 PM ET
Size
30.8 KB